SBN 0.00% 0.0¢ sun biomedical limited

Short term cash flow even if relatively small may negate the...

  1. 2,234 Posts.
    lightbulb Created with Sketch. 69
    Short term cash flow even if relatively small may negate the need to raise capital in the near future, at least at these low levels, especially given they have $1.3m in hand.

    Actual current enterprise value of the company is ridiculous given where they are at in the commercialization process and the current board (and their history of what they can do with ASX companies).
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.